Compared to healthy controls, SLE patients exhibit lower receptor-binding domain (RBD)- or spike protein subunit 1 (S1)-specific IgG titres with weaker neutralizing capacity. The gene discussed is PSMD1; the disease is systemic lupus erythematosus.